By expenditures
| Name | Title | Type |
|---|---|---|
| Regina Tuczak | Chief Financial Officer | Auditee |
| Melissa Gallagher | Chief Financial Officer | Auditee |
| Amanda Blomberg | Managing Director | Auditee |
| Patrice Sutton | CHIEF FINANCIAL OFFICER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365154 | 2024 | 2025-08-28 | Baker Tilly US LLP | $77.36M |
| 318016 | 2023 | 2024-08-28 | Baker Tilly US LLP | $67.28M |
| 29432 | 2022 | 2023-08-20 | Baker Tilly US LLP | $77.46M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 318016 | 2023 | 2024-08-28 | 1061700 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061699 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061698 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061697 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061696 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061695 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061694 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 1061693 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485258 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485257 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485256 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485255 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485254 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485253 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485252 | 2023-002 | Significant Deficiency | - | L |
| 318016 | 2023 | 2024-08-28 | 485251 | 2023-002 | Significant Deficiency | - | L |
| 29432 | 2022 | 2023-08-20 | 605154 | 2022-001 | Significant Deficiency | - | M |
| 29432 | 2022 | 2023-08-20 | 28712 | 2022-001 | Significant Deficiency | - | M |